Genetic variation of vascular endothelial growth factor pathway does not correlate with the severity of retinopathy of prematurity

T. Kusuda, S. Hikino, S. Ohga, T. Kinjo, M. Ochiai, Y. Takahata, S. Tokunaga, K. Ihara, Y. Hata, T. Hara

Research output: Contribution to journalArticle

6 Citations (Scopus)


Objective: The aim of this study was to assess the genetic effects of the vascular endothelial growth factor (VEGF) pathway on retinopathy of prematurity (ROP). Study Design: A prospective study from a tertiary center that enrolled 204 Japanese infants (<35 weeks of gestational age (GA)) having no anomalies. ROP developed in 127, but not in 77 infants. The relative severity was defined as non-severe, moderate and severe ROP for GA, based on the staging criteria. VEGF (g.-634G>C, g.+13553C>T) and VEGF-receptor (KDR g.+4422(AC)11 to 14, Flt-1 c.+6724(TG)13 to 23) gene polymorphisms and clinical variables were assessed by uni/multivariate analyses. Result: The frequency of polymorphisms did not differ between ROP and non-ROP patients. The TT genotype of g.+13553 showed a higher odds ratio for non-severe ROP than CC genotype (P=0.006). Multivariate analyses indicated that low birth weight, blood transfusion and respiratory distress syndrome, but not polymorphisms, were the risk factors of advanced ROP (≥stage 3). Conclusion: A genotype of the VEGF pathway weakly affects the severity of ROP compared with other clinical factors.

Original languageEnglish
Pages (from-to)246-250
Number of pages5
JournalJournal of Perinatology
Issue number4
Publication statusPublished - Apr 1 2011


All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this